Form 8-K Inari Medical, Inc. For: Oct 28
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
Inari Medical Inc. (NARI) PT Raised to $50 at Truist Securities
October 29, 2024 5:57 AM EDTTruist Securities analyst Richard Newitter raised the price target on Inari Medical Inc. (NASDAQ: NARI) to $50.00 (from $46.00) while maintaining a Hold rating.
The analyst comments "NARI's 3Q profit beat shld help the stock recover a bit (up +9% AMC) some of its recent pullback... More
BTIG Reiterates Buy Rating on Inari Medical Inc. (NARI)
October 29, 2024 5:47 AM EDTBTIG analyst Marie Thibault reiterated a Buy rating and $86.00 price target on Inari Medical Inc. (NASDAQ: NARI).
The analyst comments "Inari Medical reported Q3 revenue of $153.4M (+21.4% y/y and +5% sequentially), above consensus of $150.7M. NARI had previously set a Q3 sales outlook that implied ~$150M this ~$3M beat vs our expectations was driven by U.S. VTE and International sales growth. The full-year revenue outlook was... More
